SLI
1.976,27
PKT
+8,43
PKT
+0,43
%
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 11.04.25 | Givaudan Neutral | UBS AG | |
| 11.04.25 | Givaudan Hold | Deutsche Bank AG | |
| 11.04.25 | Givaudan Overweight | JP Morgan Chase & Co. | |
| 11.04.25 | Givaudan Buy | Goldman Sachs Group Inc. | |
| 10.04.25 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
| 10.04.25 | Givaudan Underperform | Jefferies & Company Inc. | |
| 10.04.25 | Zurich Insurance Overweight | Barclays Capital | |
| 10.04.25 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 10.04.25 | UBS Buy | Deutsche Bank AG | |
| 10.04.25 | Swiss Re Overweight | JP Morgan Chase & Co. | |
| 10.04.25 | Givaudan Add | Baader Bank | |
| 10.04.25 | Givaudan Overweight | JP Morgan Chase & Co. | |
| 10.04.25 | Givaudan Underperform | Jefferies & Company Inc. | |
| 10.04.25 | Novartis Neutral | UBS AG | |
| 10.04.25 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
| 09.04.25 | Novartis Neutral | UBS AG | |
| 09.04.25 | UBS Hold | Jefferies & Company Inc. | |
| 09.04.25 | Richemont Hold | Deutsche Bank AG | |
| 08.04.25 | Richemont Overweight | JP Morgan Chase & Co. | |
| 08.04.25 | ams-OSRAM Buy | Deutsche Bank AG | |
| 08.04.25 | Richemont Buy | Jefferies & Company Inc. | |
| 08.04.25 | UBS Outperform | RBC Capital Markets | |
| 08.04.25 | ams-OSRAM Buy | Jefferies & Company Inc. | |
| 07.04.25 | Roche Buy | UBS AG | |
| 07.04.25 | Novartis Buy | Deutsche Bank AG | |
| 07.04.25 | Givaudan Add | Baader Bank | |
| 07.04.25 | Roche Sell | Deutsche Bank AG | |
| 07.04.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 07.04.25 | ams-OSRAM Buy | Jefferies & Company Inc. | |
| 07.04.25 | Novartis Neutral | JP Morgan Chase & Co. | |
| 04.04.25 | Novartis Buy | Deutsche Bank AG | |
| 04.04.25 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
| 04.04.25 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 04.04.25 | Givaudan Overweight | JP Morgan Chase & Co. | |
| 03.04.25 | Roche Sell | Deutsche Bank AG | |
| 03.04.25 | Richemont Buy | UBS AG | |
| 03.04.25 | Novartis Buy | Deutsche Bank AG | |
| 03.04.25 | Novartis Outperform | Bernstein Research | |
| 03.04.25 | Roche Outperform | Bernstein Research | |
| 03.04.25 | Givaudan Buy | Goldman Sachs Group Inc. |